O	O	O	0	10	Activation	Activation	B-NP	NN	O	12	SUB	O
O	O	O	11	13	of	of	B-PP	IN	O	1	NMOD	O
T5	B-Entity	B-Entity	14	21	nuclear	nuclear	B-NP	JJ	B-protein	6	NMOD	B-protein
T5	I-Entity	I-Entity	22	28	factor	factor	I-NP	NN	I-protein	6	NMOD	I-protein
T5	I-Entity	I-Entity	28	29	-	-	O	HYPH	I-protein	6	P	I-protein
T5	I-Entity	I-Entity	29	35	kappaB	kappaB	B-NP	NN	I-protein	2	PMOD	I-protein
O	O	O	36	38	by	by	B-PP	IN	O	1	NMOD	O
O	O	O	39	57	lipopolysaccharide	lipopolysaccharide	B-NP	NN	O	7	PMOD	O
O	O	O	58	60	in	in	B-PP	IN	O	8	NMOD	O
O	O	O	61	72	mononuclear	mononuclear	B-NP	JJ	B-cell_type	11	NMOD	B-cell_type
O	O	O	73	83	leukocytes	leukocyte	I-NP	NNS	I-cell_type	9	PMOD	I-cell_type
O	O	O	84	86	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	87	96	prevented	prevent	I-VP	VBN	O	12	VC	O
O	O	O	97	99	by	by	B-PP	IN	O	13	VMOD	O
O	O	O	100	110	inhibitors	inhibitor	B-NP	NNS	O	14	PMOD	O
O	O	O	111	113	of	of	B-PP	IN	O	15	NMOD	O
O	O	O	114	123	cytosolic	cytosolic	B-NP	JJ	B-protein	19	NMOD	B-protein
O	O	O	124	137	phospholipase	phospholipase	I-NP	NN	I-protein	19	NMOD	I-protein
O	O	O	138	140	A2	A2	I-NP	NN	I-protein	16	PMOD	I-protein
O	O	O	140	141	.	.	O	.	O	12	P	O

O	O	O	143	145	In	In	B-PP	IN	O	5	VMOD	O
O	O	O	146	155	monocytes	monocyte	B-NP	NNS	B-cell_type	1	PMOD	B-cell_type
O	O	O	155	156	,	,	O	,	O	5	P	O
O	O	O	157	175	lipopolysaccharide	lipopolysaccharide	B-NP	NN	O	5	SUB	O
O	O	O	176	183	induces	induce	B-VP	VBZ	O	0	ROOT	O
O	O	O	184	193	synthesis	synthesis	B-NP	NN	O	8	NMOD	O
O	O	O	194	197	and	and	I-NP	CC	O	8	NMOD	O
O	O	O	198	206	activity	activity	I-NP	NN	O	5	OBJ	O
O	O	O	207	209	of	of	B-PP	IN	O	8	NMOD	O
O	O	O	210	213	the	the	B-NP	DT	O	16	NMOD	O
O	O	O	214	216	85	85	I-NP	CD	O	16	NMOD	O
O	O	O	216	217	-	-	I-NP	HYPH	O	16	NMOD	O
O	O	O	217	220	kDa	kDa	I-NP	NN	O	16	NMOD	O
O	O	O	221	230	cytosolic	cytosolic	I-NP	JJ	B-protein	16	NMOD	B-protein
O	O	O	231	244	phospholipase	phospholipase	I-NP	NN	I-protein	16	NMOD	I-protein
O	O	O	245	247	A2	A2	I-NP	NN	I-protein	9	PMOD	I-protein
O	O	O	247	248	.	.	O	.	O	5	P	O

O	O	O	249	253	This	This	B-NP	DT	O	2	NMOD	O
O	O	O	254	260	enzyme	enzyme	I-NP	NN	B-protein	3	SUB	B-protein
O	O	O	261	269	releases	release	B-VP	VBZ	O	0	ROOT	O
O	O	O	270	281	arachidonic	arachidonic	B-NP	JJ	O	5	NMOD	O
O	O	O	282	286	acid	acid	I-NP	NN	O	9	NMOD	O
O	O	O	287	290	and	and	O	CC	O	9	NMOD	O
O	O	O	291	295	lyso	lyso	B-NP	AFX	O	9	NMOD	O
O	O	O	295	296	-	-	I-NP	HYPH	O	9	NMOD	O
O	O	O	296	309	phospholipids	phospholipid	B-NP	NNS	O	3	OBJ	O
O	O	O	310	314	from	from	B-PP	IN	O	9	NMOD	O
O	O	O	315	324	membranes	membrane	B-NP	NNS	O	10	PMOD	O
O	O	O	325	330	which	which	B-NP	WDT	O	11	NMOD	O
O	O	O	331	334	are	be	B-VP	VBP	O	12	SBAR	O
O	O	O	335	346	metabolized	metabolize	I-VP	VBN	O	13	VC	O
O	O	O	347	349	to	to	B-PP	TO	O	14	VMOD	O
O	O	O	350	361	eicosanoids	eicosanoid	B-NP	NNS	O	22	NMOD	O
O	O	O	362	365	and	and	I-NP	CC	O	22	NMOD	O
O	O	O	366	374	platelet	platelet	I-NP	NN	B-protein	22	NMOD	B-protein
O	O	O	374	375	-	-	O	HYPH	I-protein	22	NMOD	I-protein
O	O	O	375	385	activating	activate	B-VP	VBG	I-protein	22	NMOD	I-protein
O	O	O	385	386	-	-	B-NP	HYPH	I-protein	22	NMOD	I-protein
O	O	O	386	392	factor	factor	I-NP	NN	I-protein	15	PMOD	I-protein
O	O	O	392	393	.	.	O	.	O	3	P	O

O	O	O	394	399	These	These	B-NP	DT	O	3	NMOD	O
O	O	O	400	405	lipid	lipid	I-NP	NN	O	3	NMOD	O
O	O	O	406	415	mediators	mediator	I-NP	NNS	O	4	SUB	O
O	O	O	416	424	increase	increase	B-VP	VBP	O	0	ROOT	O
O	O	O	425	433	activity	activity	B-NP	NN	O	10	NMOD	O
O	O	O	434	436	of	of	B-PP	IN	O	5	NMOD	O
O	O	O	437	450	transcription	transcription	B-NP	NN	B-protein	8	NMOD	B-protein
O	O	O	451	458	factors	factor	I-NP	NNS	I-protein	6	PMOD	I-protein
O	O	O	459	462	and	and	O	CC	O	10	NMOD	O
O	O	O	463	473	expression	expression	B-NP	NN	O	4	OBJ	O
O	O	O	474	476	of	of	B-PP	IN	O	10	NMOD	O
T6	B-Entity	B-Entity	477	485	cytokine	cytokine	B-NP	NN	B-DNA	13	NMOD	B-DNA
T6	I-Entity	I-Entity	486	491	genes	gene	I-NP	NNS	I-DNA	11	PMOD	I-DNA
O	O	O	492	502	indicating	indicate	B-VP	VBG	O	4	VMOD	O
O	O	O	503	504	a	a	B-NP	DT	O	16	NMOD	O
O	O	O	505	513	function	function	I-NP	NN	O	14	OBJ	O
O	O	O	514	517	for	for	B-PP	IN	O	16	NMOD	O
O	O	O	518	527	cytosolic	cytosolic	B-NP	JJ	B-protein	20	NMOD	B-protein
O	O	O	528	541	phospholipase	phospholipase	I-NP	NN	I-protein	20	NMOD	I-protein
O	O	O	542	544	A2	A2	I-NP	NN	I-protein	17	PMOD	I-protein
O	O	O	545	547	in	in	B-PP	IN	O	16	NMOD	O
O	O	O	548	554	signal	signal	B-NP	NN	O	23	NMOD	O
O	O	O	555	567	transduction	transduction	I-NP	NN	O	25	NMOD	O
O	O	O	568	571	and	and	I-NP	CC	O	25	NMOD	O
O	O	O	572	584	inflammation	inflammation	I-NP	NN	O	21	PMOD	O
O	O	O	584	585	.	.	O	.	O	4	P	O

O	O	O	586	588	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	589	593	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	594	599	shown	show	I-VP	VBN	O	2	VC	O
O	O	O	600	610	previously	previously	B-ADVP	RB	O	3	VMOD	O
O	O	O	611	615	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	O	616	637	trifluoromethylketone	trifluoromethylketone	B-NP	NN	O	7	NMOD	O
O	O	O	638	648	inhibitors	inhibitor	I-NP	NNS	O	12	SUB	O
O	O	O	649	651	of	of	B-PP	IN	O	7	NMOD	O
O	O	O	652	661	cytosolic	cytosolic	B-NP	JJ	B-protein	11	NMOD	B-protein
O	O	O	662	675	phospholipase	phospholipase	I-NP	NN	I-protein	11	NMOD	I-protein
O	O	O	676	678	A2	A2	I-NP	NN	I-protein	8	PMOD	I-protein
O	O	O	679	689	suppressed	suppress	B-VP	VBD	O	5	SBAR	O
T1	B-Protein	B-Protein	690	701	interleukin	interleukin	B-NP	NN	B-protein	16	NMOD	B-protein
T1	I-Protein	I-Protein	701	702	-	-	B-NP	HYPH	O	16	NMOD	O
T1	I-Protein	I-Protein	702	707	1beta	1beta	I-NP	NN	O	16	NMOD	O
O	O	O	708	715	protein	protein	I-NP	NN	O	22	NMOD	O
O	O	O	716	719	and	and	O	CC	O	22	NMOD	O
O	O	O	720	726	steady	steady	B-NP	JJ	O	22	NMOD	O
O	O	O	726	727	-	-	I-NP	HYPH	O	22	P	O
O	O	O	727	732	state	state	I-NP	NN	O	22	NMOD	O
O	O	O	733	737	mRNA	mRNA	I-NP	NN	O	22	NMOD	O
O	O	O	738	744	levels	level	I-NP	NNS	O	12	OBJ	O
O	O	O	745	747	in	in	B-PP	IN	O	22	NMOD	O
O	O	O	748	753	human	human	B-NP	JJ	B-cell_type	31	NMOD	B-cell_type
O	O	O	754	772	lipopolysaccharide	lipopolysaccharide	I-NP	NN	I-cell_type	31	NMOD	I-cell_type
O	O	O	772	773	-	-	B-VP	HYPH	I-cell_type	31	P	I-cell_type
O	O	O	773	783	stimulated	stimulate	B-NP	VBN	I-cell_type	31	NMOD	I-cell_type
O	O	O	784	794	peripheral	peripheral	I-NP	JJ	I-cell_type	31	NMOD	I-cell_type
O	O	O	795	800	blood	blood	I-NP	NN	I-cell_type	31	NMOD	I-cell_type
O	O	O	801	812	mononuclear	mononuclear	I-NP	JJ	I-cell_type	31	NMOD	I-cell_type
O	O	O	813	823	leukocytes	leukocyte	I-NP	NNS	I-cell_type	23	PMOD	I-cell_type
O	O	O	823	824	.	.	O	.	O	2	P	O

O	O	O	825	827	In	In	B-PP	IN	O	8	VMOD	O
O	O	O	828	832	this	this	B-NP	DT	O	3	NMOD	O
O	O	O	833	838	study	study	I-NP	NN	O	1	PMOD	O
O	O	O	838	839	,	,	O	,	O	8	P	O
O	O	O	840	843	the	the	B-NP	DT	O	7	NMOD	O
O	O	O	844	855	subcellular	subcellular	I-NP	JJ	O	7	NMOD	O
O	O	O	856	866	mechanisms	mechanism	I-NP	NNS	O	8	SUB	O
O	O	O	867	871	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	872	880	analyzed	analyze	I-VP	VBN	O	8	VC	O
O	O	O	881	883	by	by	B-PP	IN	O	9	VMOD	O
O	O	O	884	889	which	which	B-NP	WDT	O	10	PMOD	O
O	O	O	890	912	trifluoromethylketones	trifluoromethylketone	B-NP	NNS	O	13	SUB	O
O	O	O	913	922	interfere	interfere	B-VP	VBP	O	10	SBAR	O
O	O	O	923	927	with	with	B-PP	IN	O	13	VMOD	O
O	O	O	928	932	gene	gene	B-NP	NN	O	16	NMOD	O
O	O	O	933	943	expression	expression	I-NP	NN	O	14	PMOD	O
O	O	O	943	944	.	.	O	.	O	8	P	O

O	O	O	945	947	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	948	953	found	find	B-VP	VBD	O	0	ROOT	O
O	O	O	954	958	that	that	B-SBAR	IN	O	2	VMOD	O
O	O	O	959	963	they	they	B-NP	PRP	O	5	SUB	O
O	O	O	964	971	reduced	reduce	B-VP	VBD	O	3	SBAR	O
O	O	O	972	975	the	the	B-NP	DT	O	13	NMOD	O
O	O	O	976	983	initial	initial	I-NP	JJ	O	13	NMOD	O
T2	B-Protein	B-Protein	984	995	interleukin	interleukin	I-NP	NN	B-protein	13	NMOD	B-protein
T2	I-Protein	I-Protein	995	996	-	-	B-NP	HYPH	O	13	P	O
T2	I-Protein	I-Protein	996	1001	1beta	1beta	I-NP	NN	B-RNA	13	NMOD	B-RNA
O	O	O	1002	1006	mRNA	mRNA	I-NP	NN	I-RNA	13	NMOD	I-RNA
O	O	O	1007	1020	transcription	transcription	I-NP	NN	O	13	NMOD	O
O	O	O	1021	1025	rate	rate	I-NP	NN	O	5	OBJ	O
O	O	O	1026	1033	through	through	B-PP	IN	O	5	VMOD	O
O	O	O	1034	1044	prevention	prevention	B-NP	NN	O	14	PMOD	O
O	O	O	1045	1047	of	of	B-PP	IN	O	15	NMOD	O
O	O	O	1048	1059	degradation	degradation	B-NP	NN	O	16	PMOD	O
O	O	O	1060	1062	of	of	B-PP	IN	O	17	NMOD	O
T3	B-Protein	B-Protein	1063	1072	inhibitor	inhibitor	B-NP	NN	O	22	NMOD	O
T3	I-Protein	I-Protein	1072	1073	-	-	B-NP	HYPH	O	22	NMOD	O
T3	I-Protein	I-Protein	1073	1079	kappaB	kappaB	I-NP	NN	B-protein	22	NMOD	B-protein
T3	I-Protein	I-Protein	1080	1085	alpha	alpha	I-NP	NN	I-protein	18	PMOD	I-protein
O	O	O	1085	1086	.	.	O	.	O	2	P	O

O	O	O	1087	1099	Consequently	Consequently	B-ADVP	RB	O	17	VMOD	O
O	O	O	1099	1100	,	,	O	,	O	17	P	O
O	O	O	1101	1110	cytosolic	cytosolic	B-NP	JJ	O	4	NMOD	O
O	O	O	1111	1121	activation	activation	I-NP	NN	O	17	SUB	O
O	O	O	1121	1122	,	,	O	,	O	17	P	O
O	O	O	1123	1130	nuclear	nuclear	B-NP	JJ	O	7	NMOD	O
O	O	O	1131	1144	translocation	translocation	I-NP	NN	O	17	SUB	O
O	O	O	1145	1148	and	and	I-NP	CC	O	7	NMOD	O
T7	B-Entity	B-Entity	1149	1152	DNA	DNA	I-NP	NN	O	8	PMOD	O
O	O	O	1152	1153	-	-	O	HYPH	O	9	NMOD	O
O	O	O	1153	1160	binding	binding	B-NP	NN	O	10	PMOD	O
O	O	O	1161	1163	of	of	B-PP	IN	O	11	NMOD	O
T8	B-Entity	B-Entity	1164	1171	nuclear	nuclear	B-NP	JJ	B-protein	16	NMOD	B-protein
T8	I-Entity	I-Entity	1172	1178	factor	factor	I-NP	NN	I-protein	16	NMOD	I-protein
T8	I-Entity	I-Entity	1178	1179	-	-	O	HYPH	I-protein	16	NMOD	I-protein
T8	I-Entity	I-Entity	1179	1185	kappaB	kappaB	B-NP	NN	I-protein	12	PMOD	I-protein
O	O	O	1186	1190	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1191	1200	decreased	decrease	I-VP	VBN	O	17	VC	O
O	O	O	1200	1201	.	.	O	.	O	17	P	O

O	O	O	1202	1224	Trifluoromethylketones	Trifluoromethylketone	B-NP	NNS	O	2	SUB	O
O	O	O	1225	1235	ameliorate	ameliorate	B-VP	VBP	O	0	ROOT	O
O	O	O	1236	1243	chronic	chronic	B-NP	JJ	O	4	NMOD	O
O	O	O	1244	1256	inflammation	inflammation	I-NP	NN	O	2	OBJ	O
O	O	O	1257	1259	in	in	B-ADVP	FW	O	2	VMOD	O
O	O	O	1260	1264	vivo	vivo	I-ADVP	FW	O	5	AMOD	O
O	O	O	1264	1265	.	.	O	.	O	2	P	O

O	O	O	1266	1270	Thus	Thus	B-ADVP	RB	O	6	VMOD	O
O	O	O	1270	1271	,	,	O	,	O	6	P	O
O	O	O	1272	1276	this	this	B-NP	DT	O	5	NMOD	O
O	O	O	1277	1288	therapeutic	therapeutic	I-NP	JJ	O	5	NMOD	O
O	O	O	1289	1296	potency	potency	I-NP	NN	O	6	SUB	O
O	O	O	1297	1300	may	may	B-VP	MD	O	0	ROOT	O
O	O	O	1301	1307	reside	reside	I-VP	VB	O	6	VC	O
O	O	O	1308	1310	in	in	B-PP	IN	O	7	VMOD	O
O	O	O	1311	1320	retention	retention	B-NP	NN	O	8	PMOD	O
O	O	O	1321	1323	of	of	B-PP	IN	O	9	NMOD	O
O	O	O	1324	1332	inactive	inactive	B-NP	JJ	O	15	NMOD	O
T9	B-Entity	B-Entity	1333	1340	nuclear	nuclear	I-NP	JJ	B-protein	15	NMOD	B-protein
T9	I-Entity	I-Entity	1341	1347	factor	factor	I-NP	NN	I-protein	15	NMOD	I-protein
T9	I-Entity	I-Entity	1347	1348	-	-	B-NP	HYPH	I-protein	15	NMOD	I-protein
T9	I-Entity	I-Entity	1348	1354	kappaB	kappaB	I-NP	NN	I-protein	10	PMOD	I-protein
O	O	O	1355	1357	in	in	B-PP	IN	O	7	VMOD	O
O	O	O	1358	1361	the	the	B-NP	DT	O	18	NMOD	O
O	O	O	1362	1369	cytosol	cytosol	I-NP	NN	O	16	PMOD	O
O	O	O	1370	1377	thereby	thereby	B-VP	RB	O	20	VMOD	O
O	O	O	1378	1388	abrogating	abrogate	I-VP	VBG	O	7	VMOD	O
T4	B-Protein	B-Protein	1389	1400	interleukin	interleukin	B-NP	NN	B-protein	25	NMOD	B-protein
T4	I-Protein	I-Protein	1400	1401	-	-	B-NP	HYPH	O	25	NMOD	O
T4	I-Protein	I-Protein	1401	1406	1beta	1beta	I-NP	NN	B-DNA	25	NMOD	B-DNA
O	O	O	1407	1411	gene	gene	I-NP	NN	I-DNA	25	NMOD	I-DNA
O	O	O	1412	1425	transcription	transcription	I-NP	NN	O	20	OBJ	O
O	O	O	1425	1426	.	.	O	.	O	6	P	O
